`Filed: July 8, 2019
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`_________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_________________
`
`AMNEAL PHARMACEUTICALS LLC,
`Petitioner,
`
`v.
`
`ALKERMES PHARMA IRELAND LIMITED,
`Patent Owner.
`
`_________________
`
`Case IPR2018-00943
`Patent No. 7,919,499
`_________________
`
`PATENT OWNER’S REQUEST FOR ORAL ARGUMENT
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.70, the Board’s Scheduling Order dated
`
`IPR2018-00943
`Patent 7,919,499
`
`
`
`November 7, 2018 (Paper 9), and the Notice of Joint Stipulation to Change Due
`
`Date 3, dated May 20, 2019 (Paper 21), Patent Owner Alkermes Pharma Ireland
`
`Limited submits this request for oral argument on all issues in this proceeding.
`
`Patent Owner requests 45 minutes of total argument time for each party. In
`
`addition, given the number of individuals expected to attend for each party, Patent
`
`Owner requests that oral arguments be held in Hearing Room A.
`
`
`
`Dated: July 8, 2019
`
`Respectfully submitted,
`
`By: /Naveen Modi/
`Naveen Modi (Reg. No. 46,224)
`Counsel for Patent Owner
`
`
`
`1
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`IPR2018-00943
`Patent 7,919,499
`
`I hereby certify that on July 8, 2019, I caused a true and correct copy of the
`
`foregoing Patent Owner’s Request for Oral Argument to be served electronically
`
`on Petitioner at the following addresses:
`
`Michael H. Teschner
`Tedd W. Van Buskirk
`Lerner, David, Littenberg,
`Krumholz & Mentlik, LLP
`600 South Avenue West
`Westfield, NJ 07090
`
`MTeschner.ipr@ldlkm.com
`tvanbuskirk@lernerdavid.com
`litigation@lernerdavid.com
`
`
`By: /NaveenModi/
`Naveen Modi (Reg. No. 46,224)
`Counsel for Patent Owner
`
`
`
`
`
`
`
`Dated: July 8, 2019
`
`
`
`
`